Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5462
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application ; volume:28 ; number:9 ; day:11 ; month:6 ; year:2021 ; pages:588-601 ; date:9.2021
Gene therapy ; 28, Heft 9 (11.6.2021), 588-601, 9.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41434-021-00271-9
- URN
-
urn:nbn:de:101:1-2023020509171613687269
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schwarze, Lea Isabell
- Głów, Dawid
- Sonntag, Tanja
- Uhde, Almut
- Fehse, Boris
- SpringerLink (Online service)
Other Objects (12)
Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Influence of gender in predicting CCR5 coreceptor usage
The HIV co-receptor CCR5 regulates osteoclast function
Designer nuclease-assisted targeting to engineer mammalian genomes
Designer Nuclease-Assisted Targeting to Engineer Mammalian Genomes
Validation of an enhanced sensitivity Trofile™ HIV-1 co-receptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5
Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5
5’-nuclease
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5
Modification of the porcine genome using nuclease-based targeting tools
Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Influence of gender in predicting CCR5 coreceptor usage
The HIV co-receptor CCR5 regulates osteoclast function
Designer nuclease-assisted targeting to engineer mammalian genomes
Designer Nuclease-Assisted Targeting to Engineer Mammalian Genomes
Validation of an enhanced sensitivity Trofile™ HIV-1 co-receptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5
Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5
5’-nuclease
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5
Modification of the porcine genome using nuclease-based targeting tools
Correction: Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
Influence of gender in predicting CCR5 coreceptor usage
The HIV co-receptor CCR5 regulates osteoclast function
Designer nuclease-assisted targeting to engineer mammalian genomes
Designer Nuclease-Assisted Targeting to Engineer Mammalian Genomes
Validation of an enhanced sensitivity Trofile™ HIV-1 co-receptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5
Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5
5’-nuclease
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5
Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
Identification and characterization of two novel proteins interacting with the chemokine- and HIV-1 co-receptor CCR5